Cancer predisposition in diabetics: Risk factors considered for predictive diagnostics and targeted Preventive measures

28Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Diabetes mellitus (DM) is a lifelong progressive disease with high morbidity and mortality worldwide. Whereas cardiovascular complications are well-known for DM, increasing evidence indicates that diabetics are predisposed to cancer. Understanding of molecular pathomechanisms of cancer in DM is of great importance. Dysregulation of glucose/insulin homeostasis leads to increased production of Reactive Oxygen/Nitrogen Species (ROS/RNS) and consequent damage to chromosomal/ mitochondrial DNA, a frequent finding in DM. Long-term accumulation of modified/damaged DNA is wellacknowledged as triggering cancer. DNA-repair is a highly energy consuming process provoking increased mitochondrial activity. Particularly dangerous is a provoked activity of damaged mitochondria leading to a "vicious circle" lowering energy supply and potentiating ROS/RNS production. Mitochondrial dysfunction may be implicated in pathomechanisms of diabetes-related cancer. High risk for infectious disorders and induced viral proto-oncogenic activity may further contribute to cancer provocation. Much attention should be focused on preventive measures in diabetic healthcare, in order to restrict severe diabetesrelated complications. © European Association for Predictive, Preventive and Personalised Medicine 2010.

Cite

CITATION STYLE

APA

Cebioglu, M., Schild, H. H., & Golubnitschaja, O. (2010). Cancer predisposition in diabetics: Risk factors considered for predictive diagnostics and targeted Preventive measures. EPMA Journal, 1(1), 130–137. https://doi.org/10.1007/s13167-010-0015-4

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free